Department of Veterans Affairs July 22, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 4 of 4
Agency Information Collection Activities Under OMB Review
In compliance with the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501-3521), this notice announces that the Board of Veterans' Appeal (BVA), Department of Veterans Affairs, has submitted the collection of information abstracted below to the Office of Management and Budget (OMB) for review and comment. The PRA submission describes the nature of the information collection and its expected cost and burden; it includes the actual data collection instrument.
Notice of Intent To Grant an Exclusive License
Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant to CellCyte Genetics, Inc., PO Box 493, Kirkland, WA 98083 USA an exclusive license to practice the following patent applications: U.S. Provisional Patent Application Serial No. 60/364,498 filed March 15, 2002, entitled ``Methods and Compositions for Directing Cells to Target Organs''; U.S. Patent Application Serial No. 10/388,964 filed March 14, 2003, entitled ``Methods and Compositions for Directing Cells to Target Organs''; International Patent Application Serial No. PCT/US03/07834 filed March 13, 2003, entitled ``Methods and Compositions for Directing Cells to Target Organs''; International Patent Application Serial No. PCT/US03/07934 filed March 13, 2003, entitled ``Methods and Compositions Using Cellular Asialodeterminants and Glycoconjugates for Targeting Cells to Tissues and Organs''; International Patent Application Serial No. PCT/US03/32602 filed October 10, 2003 entitled ``Detection/Localization and Staging of Tumors Using Labeled Activated Lymphocytes Directed to a Tumor Specific Epitope'' and International Patent Application Serial No. PCT/US03/07836 filed March 14, 2003, entitled ``Methods and Compositions for Directing Cells to Target Organs''.
Notice of Intent To Grant an Exclusive License
Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant Global Therapy Monitoring LLC, 6931 Arlington Road, Bethesda, MD 20814 USA an exclusive license to practice the following patent applications: U.S. Provisional Patent Application Serial No. 60/547,052 filed February 25, 2004, entitled ``Methods for Diagnosing and Treating Bladder Cancer''; U.S. Provisional Patent Application Serial No. 60/532,889 filed December 30, 2003, entitled ``Macrophage Migration Inhibitory Factor (MIF) as a Marker for Urological Inflammatory Disease''; U.S. Patent Application Serial No. 10/644,797 filed on August 21, 2003, and International Patent Application Serial No. PCT/US04/05288 filed on February 24, 2004, entitled ``Serum Macrophage Migration Inhibitory Factor (MIF) as a Marker for Prostate Cancer.''
VA Fleet Alternative Fuel Vehicle (AFV) Program Report
In accordance with the Energy Policy Act of 1992 (EPAct) (42 U.S.C. 13211-13219) as amended by the Energy Conservation Reauthorization Act of 1998 (Pub. L. 105-388), the Department of Veterans Affairs' annual alternative fuel reports are available on the following Department of Veterans Affairs Web site: https://www.va.gov/ afv.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.